ARTELO BIOSCIENCES, INC. Proceeds from (Repayments of) Related Party Debt
ARTELO BIOSCIENCES, INC. (ARTL) reported Proceeds from (Repayments of) Related Party Debt of $0 for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2022-08-09
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for the quarter ending 2022-06-30 was $0.00.
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for the quarter ending 2022-03-31 was $0.00.
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for the quarter ending 2021-11-30 was $0.00.
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for the quarter ending 2021-08-31 was $338.00.
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for fiscal 2021 was -$8.00K.
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for fiscal 2020 was -$5.00K.
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for fiscal 2019 was -$17.23K.
- ARTELO BIOSCIENCES, INC. proceeds from (repayments of) related party debt for fiscal 2018 was -$18.06K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 3 month as first filed | Proceeds from (Repayments of) Related Party Debt 4 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month | Proceeds from (Repayments of) Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | |||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | -$1.00K 10-KT · filed 2022-03-21 | ||||||
| 2021-11-30 | $0.00 10-Q · filed 2022-01-12 | $338.00 derived: sum of 2 quarters · filed 2022-03-21 | |||||
| 2021-08-31 | $338.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | -$8.00K 10-KT · filed 2022-03-21 | |||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$7.00K 10-Q · filed 2022-08-09 | |||||
| 2021-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | -$8.34K 10-Q · filed 2021-07-12 | |||||
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-12 | ||||||
| 2021-02-28 | -$7.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | -$8.34K 10-Q · filed 2021-04-13 | -$10.30K derived: sum of 3 quarters · filed 2022-03-21 | -$10.30K derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2020-12-31 | -$1.00K 10-KT · filed 2022-03-21 | ||||||
| 2020-11-30 | -$1.00K 10-Q · filed 2022-01-12 | -$1.09K 10-Q · filed 2021-01-14 | -$2.96K derived: sum of 2 quarters · filed 2022-03-21 | -$2.96K derived: sum of 3 quarters · filed 2022-03-21 | -$2.96K derived: sum of 4 quarters · filed 2022-03-21 | ||
| 2020-08-31 | -$1.96K derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | -$1.96K derived: sum of 2 quarters · filed 2022-03-21 | -$1.96K derived: sum of 3 quarters · filed 2022-03-21 | -$5.00K 10-KT · filed 2022-03-21 | -$4.71K 10-K · filed 2020-11-04 | ||
| 2020-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | $0.00 derived: sum of 2 quarters · filed 2021-07-12 | -$3.04K 10-Q · filed 2021-07-12 | -$12.18K derived: sum of 4 quarters · filed 2021-07-12 | |||
| 2020-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | -$3.04K 10-Q · filed 2021-04-13 | -$12.18K derived: sum of 3 quarters · filed 2021-04-13 | -$15.05K derived: sum of 4 quarters · filed 2021-04-13 | |||
| 2019-11-30 | -$3.04K 10-Q · filed 2021-01-14 | -$12.18K derived: sum of 2 quarters · filed 2021-01-14 | -$15.05K derived: sum of 3 quarters · filed 2021-01-14 | -$19.71K derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | -$9.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | -$12.01K derived: sum of 2 quarters · filed 2020-11-04 | -$16.67K derived: sum of 3 quarters · filed 2020-11-04 | -$17.23K 10-K · filed 2020-11-04 | |||
| 2019-05-31 | -$2.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-13 | -$7.53K derived: sum of 2 quarters · filed 2020-07-13 | -$8.09K 10-Q · filed 2020-07-13 | -$9.54K derived: sum of 4 quarters · filed 2020-07-13 | |||
| 2019-02-28 | -$4.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | -$5.22K 10-Q · filed 2020-04-13 | -$6.67K derived: sum of 3 quarters · filed 2020-04-13 | -$7.43K derived: sum of 4 quarters · filed 2020-04-13 | |||
| 2018-11-30 | -$558.00 10-Q · filed 2020-01-14 | -$2.01K derived: sum of 2 quarters · filed 2020-01-14 | -$2.77K derived: sum of 3 quarters · filed 2020-01-14 | -$10.11K derived: sum of 4 quarters · filed 2020-01-14 | |||
| 2018-08-31 | -$1.45K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | -$2.21K derived: sum of 2 quarters · filed 2019-12-18 | -$9.55K derived: sum of 3 quarters · filed 2019-12-18 | -$18.06K 10-K/A · filed 2019-12-18 | |||
| 2018-05-31 | -$759.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-15 | -$8.10K derived: sum of 2 quarters · filed 2019-07-15 | -$16.60K 10-Q · filed 2019-07-15 | ||||
| 2018-02-28 | -$7.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | -$15.84K 10-Q · filed 2019-04-15 | |||||
| 2017-11-30 | -$8.51K 10-Q · filed 2019-01-14 | ||||||
| 2017-08-31 | -$11.32K 10-K · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |